Skip to main content

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Reports ‘Incredibly Positive’ Market Reception to Its NurseMagic(TM) App

Amesite (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today reported that its NurseMagic(TM) app saw a 27% increase in users. The increase followed the release of social media videos (TikTok and Instagram) created through the company’s engagement with influencer Nurse Hailey, who has over 510,000 followers across her social media channels. The latest posts follow other releases through engagement with other influencers. The company also announced that following its debut in the app store, NurseMagic(TM) charted at #33 in the medical category for free tools.

“We already knew that NurseMagic(TM) would be useful to the 5.2 million nurses in the U.S., given that this large, essential professional has no AI-powered, direct support. We now know that NurseMagic(TM) is incredibly useful to an even wider audience, including home health care (with over 3.9 million professionals) and other segments. The market reception to our proprietary technology has been incredibly positive and we look forward to moving into enterprise relationships, in addition to growing our B2C user base,” said CEO Dr. Ann Marie Sasry.

To view the full press release, visit https://ibn.fm/DrtU9

About Amesite Inc.

Amesite is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, including its higher ed platform that offers professional learning. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic(TM), the company’s recently launched mobile app, streamlines creation of nurse notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. The Preacto(TM) (beta) is a personal safety application designed to provide real-time alerts and guidance in the event of emergency situations, including active shooter incidents. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.